Drug Shortage Report for CYTARABINE INJECTION

Last updated on 2017-10-13 History
Report ID 1059
Drug Identification Number 02126656
Brand name CYTARABINE INJECTION
Common or Proper name CYTARABINE
Company Name PFIZER CANADA ULC
Active Ingredient(s) CYTARABINE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Packaging size 1g/mL X 10
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2013-06-15
Actual start date 2013-06-15
Estimated end date Unknown
Actual end date 2017-09-20
Shortage status Resolved
Updated date 2017-10-13
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-10-13 French Compare
v3 2017-10-13 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare